Preeclampsia
- A case of HELLP syndrome at 19+2 weeks of gestation
- Adverse pregnancy outcomes in women at increased risk of preterm preeclampsia
- Angiogenic markers and maternal echocardiographic indices in women with hypertension in pregnancy
- Arterial health abnormalities in women with preeclampsia: contributing role of central obesity
- Arterial health after preeclampsia: role of chronic hypertension
- ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index
- ASPRE trial: effects of aspirin on serum PAPP-A and PlGF trajectories in pregnancy
- Association between sFlt-1/PlGF ratio and incidence of intrauterine growth restriction
- Association between sFlt-1/PlGF ratio and incidence of maternal-fetal and neonatal complications
- Association of preeclampsia with demographic characteristics in pregnant women
- Can Pravastatin/L-arginine therapy improve placental perfusion in singleton pregnancies?
- Cardiac function in first trimester in women with preeclampsia
- Cardiac function in women with first trimester risk of preeclampsia: case-control study
- Cerebral Doppler and fetal vasoconstriction: hemodynamics and clinical relevance
- Changes in uterine Doppler and circulating angiogenic factors in the third trimester
- Circulating neutrophil extracellular traps contribute to endothelial dysfunction in preeclampsia
- Clinical effectiveness of routine first-trimester combined screening for preeclampsia
- Endothelial damage and complement dysregulation in fetuses from preeclamptic mothers
- Epidemiology and perinatal outcomes of early-onset preeclampsia
- Evaluation of first trimester maternal serum glycosylated fibronectin for preeclampsia screening
- Evaluation of sFlt-1/PlGF ratio and adverse outcomes in preterm preeclampsia
- Evolution of sFlt-1/PlGF ratio and blood pressure levels in twin pregnancies
- Fetal aortic intima-media thickness measurement as a second-trimester predictor of preeclampsia
- Fetal growth restriction in preeclamptic pregnancy as a predictor of adverse neonatal outcomes
- FMF vs NICE screening for preeclampsia in first trimester
- Glycosylated Fibronectin as point of care test in cases of placental dysfunction
- Home telemonitoring versus hospital care in complicated pregnancies in the Netherlands
- Hypertensive crisis: cardiovascular resistance index for prediction of labetalol response
- Hypertensive disorders of pregnancy after multifetal pregnancy reduction: a meta-analysis
- Long-term risk of chronic arterial hypertension in pregnant women with a history of preeclampsia
- Machine learning approach for the prediction of preeclampsia in a middle-income country
- Maternal and neonatal outcomes in acute fatty liver of pregnancy and HELLP syndrome
- Maternal and perinatal outcomes in users of aspirin as prevention of preterm preeclampsia
- MATERNAL CARDIAC FUNCTION AND GEOMETRY FOR THE PREDICTION OF LATE-PLACENTAL INSUFFICIENCY AT THE BEGINNING OF THIRD-TRIMESTER
- Maternal-fetal medicine program and pregnancy outcomes in severe preeclampsia
- Mid-trimester uterine artery Doppler for aspirin discontinuation
- Myocardial remodelling in chronic arterial hypertension as a predictor of adverse pregnancy outcomes
- Ophthalmic artery Doppler in the complementary diagnosis of preeclampsia: a meta-analysis
- PAPP-A in the first trimester of pregnancy as a predictor of preeclampsia
- Performance of a machine learning approach to predict preterm preeclampsia
- Postpartum PIGF concentration predicts abnormal blood pressure in early puerperium
- Potential biomarkers for late-onset and term preeclampsia
- Prediction and prevention of preeclampsia: Brazilian guidelines 2023
- Prediction model of hypertensive disorders in pregnancy with the sFlt-1/PlGF ratio
- Prediction of placental dysfunction in pregnancies with systemic lupus erythematosus
- Pregnant women at high risk of preeclampsia and prophylactic aspirin in low resource settings
- Preterm preeclampsia screening: phenotypic biomarker models and robust prediction models
- Role of circulating placenta-derived extracellular vesicles in preeclampsia
- Screening and prevention of preeclampsia: audit and literature review
- Screening for late preeclampsia at 35-38 weeks`gestation
- Stage B heart failure in pregnancies with hypertensive disease in pregnancy
- The association of IL-17 and PlGF/sENG ratio in preeclampsia and adverse pregnancy outcomes
- The fourth trimester clinic: a quality improvement project for preeclamptic patients
- The impact of the implementation of preeclampsia screening in the first trimester
- The value of C-reactive protein in the prediction of preeclampsia
- Urinary congophilia in triaging women with hypertensive disorders of pregnancy
- Uterine artery doppler examination in pregnancies with GDM and pregnancies with GDM and preeclampsia, in the 1st trimester and throughout pregnancy